drugset
drugset / Trial / NCT01939093

Therapeutic Effect of Quetiapine on Methamphetamine-Induced Psychosis

NCT01939093 ↗

Phase 4 Completed 80 enrolled Chulalongkorn University National Research Council of Thailand · collabThanyarak Institute · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

The aims of this study are to compare the antipsychotic and adverse events of quetiapine, an atypical antipsychotic drug, to haloperidol, a standard treatment for primary psychotic disorder, in individuals with MAP.

Timeline

Start
2010-03
Primary completion
2011-09
Completion
2011-09

Drugs

EvaluationDrugModalityDoseRoute
Background Cinnarizine Small molecule — —
Background Diazepam Small molecule 10 mg Intravenous

Indications

methamphetamine-induced psychosis